GAVIOLI, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 13.909
AS - Asia 7.014
EU - Europa 4.307
SA - Sud America 1.059
AF - Africa 158
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.471
Nazione #
US - Stati Uniti d'America 13.632
SG - Singapore 2.739
CN - Cina 1.757
BR - Brasile 836
VN - Vietnam 821
PL - Polonia 765
UA - Ucraina 683
DE - Germania 618
IT - Italia 616
HK - Hong Kong 540
GB - Regno Unito 444
TR - Turchia 409
FI - Finlandia 267
FR - Francia 243
SE - Svezia 219
RU - Federazione Russa 148
IN - India 141
JP - Giappone 132
CA - Canada 125
MX - Messico 108
BD - Bangladesh 90
AR - Argentina 86
ID - Indonesia 82
BE - Belgio 72
NL - Olanda 63
ZA - Sudafrica 59
IQ - Iraq 51
ES - Italia 39
PK - Pakistan 35
CO - Colombia 31
VE - Venezuela 28
LT - Lituania 25
PH - Filippine 25
MY - Malesia 24
CL - Cile 23
MA - Marocco 23
SA - Arabia Saudita 23
EC - Ecuador 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 20
AU - Australia 18
IR - Iran 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
PY - Paraguay 16
AT - Austria 15
AL - Albania 12
JO - Giordania 12
KE - Kenya 12
IE - Irlanda 11
DZ - Algeria 10
EG - Egitto 9
JM - Giamaica 9
OM - Oman 9
PA - Panama 8
PE - Perù 8
RO - Romania 8
KR - Corea 7
LB - Libano 7
SN - Senegal 7
TT - Trinidad e Tobago 7
KZ - Kazakistan 6
MD - Moldavia 6
NP - Nepal 6
UY - Uruguay 6
CH - Svizzera 5
CR - Costa Rica 5
ET - Etiopia 5
GR - Grecia 5
IL - Israele 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
DO - Repubblica Dominicana 4
LY - Libia 4
RS - Serbia 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AZ - Azerbaigian 3
HN - Honduras 3
HR - Croazia 3
NI - Nicaragua 3
TW - Taiwan 3
BO - Bolivia 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LK - Sri Lanka 2
MT - Malta 2
NO - Norvegia 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
Totale 26.448
Città #
Singapore 1.747
Ashburn 1.547
Fairfield 1.283
Woodbridge 1.108
Houston 894
Warsaw 757
San Jose 744
Jacksonville 730
Ann Arbor 726
Chandler 684
Beijing 588
Santa Clara 554
Hong Kong 527
Seattle 515
Wilmington 456
Cambridge 439
Dallas 292
Ho Chi Minh City 258
Los Angeles 254
Ferrara 231
Izmir 231
Hanoi 207
New York 188
Nanjing 181
Munich 154
Princeton 149
San Diego 145
Tokyo 130
Lauterbourg 129
Boardman 107
Milan 95
São Paulo 92
Shanghai 90
Helsinki 83
The Dalles 79
Mexico City 74
Buffalo 72
Brussels 70
Shenyang 68
Council Bluffs 65
Hefei 63
Nanchang 56
London 53
Montreal 51
Turku 50
Dearborn 49
Orem 48
Jakarta 47
Tianjin 47
Bologna 46
Addison 45
San Mateo 45
Da Nang 43
Haiphong 43
Changsha 42
Chicago 42
Hebei 42
Bremen 38
Jinan 37
Boston 36
Chennai 36
Falls Church 36
Brooklyn 35
Frankfurt am Main 33
Atlanta 32
Jiaxing 31
San Francisco 30
Stockholm 30
Amsterdam 29
Phoenix 29
Johannesburg 28
Toronto 28
Mountain View 27
Porto Alegre 27
Rio de Janeiro 27
Guangzhou 26
Manchester 25
Dong Ket 23
Falkenstein 23
Poplar 23
Auburn Hills 21
Denver 21
Moscow 21
Tashkent 20
Belo Horizonte 19
Zhengzhou 19
Rome 18
Brasília 17
Columbus 17
Des Moines 17
Dhaka 17
Ningbo 17
Norwalk 17
Ardabil 16
Baghdad 16
Modena 16
Redwood City 16
Ankara 15
Istanbul 15
Philadelphia 15
Totale 18.594
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 399
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 356
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 276
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 273
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 269
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 257
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 255
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 253
Arecoline tripeptide inhibitors of proteasome 246
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 242
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 242
Association between different anti-Tat antibody isotypes and HIV disease progression: Data from an African cohort 235
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 234
Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline 230
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 229
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 221
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 219
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 218
Modulation of neutrophil functions by activated platelet release factors 215
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 214
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 212
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 212
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 211
Phosphinic platinum complexes with 8-thiotheophylline derivatives: Synthesis, characterization, and antiproliferative activity 210
Vinyl ester-based cyclic peptide proteasome inhibitors 210
Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration 210
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 209
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 209
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8 208
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 207
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 207
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins 205
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 202
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 201
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 199
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells 199
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 198
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 198
Attivita' tumoricida dei neutrofili 198
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 197
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 197
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 195
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 195
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 194
A new approach to UV protection by direct surface functionalization of TiO2 with the antioxidant polyphenol dihydroxyphenyl benzimidazole carboxylic acid 193
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 191
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 189
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 188
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 188
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 187
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 185
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 184
null 183
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells 182
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 182
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 180
CULTURED HUMAN FIBROBLASTS ACQUIRE ADHESIVENESS FOR NEUTROPHILS AFTER STIMULATION 179
null 179
Novel oleanolic vinyl boronates: synthesis and antitumor activity 179
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 178
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 178
ANTI-INFLAMMATORY AGENTS INHIBIT NEUTROPHIL CYTOTOXIC ACTIVITY TOWARDS ERYTHROLEUKEMIC HUMAN CELLS 177
The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress 175
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 175
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 174
ACTION MECHANISM OF ACTIVATORS OF NEUTROPHIL-MEDIATED CYTOTOXICITY 172
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 172
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 172
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 170
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 170
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 169
ACTIVATED HUMAN FIBROBLASTS ADHERE TO NEUTROPHILS 169
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 167
null 167
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 165
HLA B51 antigen associated with neutrophil hyper-reactivity 164
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 164
Dielectrophoresis (DEP) based Lab-on-a-chip devices for real-time monitoring of the activity of cytotoxic T-lymphocytes. 163
Expression and functional A3 adenosine receptors in human lymphocytes 162
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 162
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 162
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 161
Expression and functionality of adenosine receptors in human blood cells 159
Expression of functional A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. 158
alpha,beta-Unsaturated Carbonyl System of Chalcone-Based Derivatives Is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells 155
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 154
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 154
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity 151
ACTIVATION OF NEUTROPHIL CYTOTOXICITY BY SYNERGISTIC ACTION OF TPA AND TARGET IMMUNIZATION 150
New cyclic peptide proteasome inhibitors 150
Triggering of neutrophil cytotoxicity against an antibody-coated tumour target by TPA 148
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 148
NEUTROPHIL CR1 RECEPTOR: RELATIONSHIP BETWEEN EXPRESSION LEVEL AND CYTOTOXICITY IN HEALTHY AND CHRONIC MYELOID LEUKEMIA 146
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 145
c-Myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells 145
Vaccines containing the HIV tat protein as an adjuvant for the enhancement of cytotoxic T-cell responses 144
Protein kinase C mediates human neutrophil cytotoxicity 143
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 142
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population 141
Immune escape by Epstein-Barr virus (EBV) carrying burkitt's lymphoma: In vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells 141
Totale 19.297
Categoria #
all - tutte 109.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 884
Totale 110.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021732 0 0 0 0 0 0 0 0 0 321 288 123
2021/20221.776 53 158 154 112 93 58 116 96 75 119 151 591
2022/20231.594 168 84 78 215 254 230 84 133 192 10 84 62
2023/2024816 80 126 34 27 50 151 35 61 11 22 17 202
2024/20253.436 82 78 290 162 442 303 64 176 580 339 512 408
2025/20269.314 1.093 344 987 1.212 1.416 737 1.227 531 895 872 0 0
Totale 26.682